U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 15

1.

Expression data from GW9662 treated FVB wild-type mouse mammary tumors

(Submitter supplied) Microarrays were used to analyse global gene expression changes in tumors from wild-type mice treated with GW9662
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL8321
2 Samples
Download data: CEL
Series
Accession:
GSE33762
ID:
200033762
2.

Expression data from RU486 treated FVB wild-type and MMTV- PAX8PPARg mouse mammary tumors

(Submitter supplied) To determine if RU-486 would be effective as a chemopreventive agent, microarrays were used to analyse global gene expression changes in wild-type vs. MMTV-PAX8PPARg mice to determine their differential response to RU486
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL8321
4 Samples
Download data: CEL
Series
Accession:
GSE33753
ID:
200033753
3.

AKT antagonist AZD5363 influences estrogen receptor function in endocrine resistant breast cancer and synergizes with fulvestrant (ICI182780) in vivo

(Submitter supplied) Phosphoinositide-3-kinase/protein-kinaseB/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling plays an important role in breast cancer (BC). Its interaction with estrogen receptor (ER) signalling becomes more complex and inter-dependent with acquired endocrine resistance. Targeting mTOR combined with endocrine therapy has shown clinical utility, however, a negative feedback-loop exists downstream of PI3K/AKT/mTOR. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
12 Samples
Download data: TXT
Series
Accession:
GSE69893
ID:
200069893
4.

Expression data from MCF7 wt and MCF7/HER2-18 xenografts

(Submitter supplied) To investigate molecular mechanisms of resistance, we used two different in vivo xenograft models of estrogen receptor-positive (ER+) breast cancer, with or without HER2 over-expression (MCF7/HER2-18 and MCF7 wt, respectively). Mice with established tumors were assigned to the following treatment groups: continued estrogen supplementation (E2), estrogen deprivation (ED), ED plus tamoxifen (Tam), all with or without the EGFR tyrosine kinase inhibitor gefinitinib (G). more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
65 Samples
Download data: CEL
Series
Accession:
GSE8141
ID:
200008141
5.

Expression data from MCF7 wt xenografts

(Submitter supplied) To investigate molecular mechanisms of resistance, we used two different in vivo xenograft models of estrogen receptor-positive (ER+) breast cancer, with or without HER2 over-expression (MCF7/HER2-18 and MCF7 wt, respectively). Mice with established tumors were assigned to the following treatment groups: continued estrogen supplementation (E2), estrogen deprivation (ED), ED plus tamoxifen (Tam), all with or without the EGFR tyrosine kinase inhibitor gefinitinib (G). more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
14 Samples
Download data: CEL, XLS
Series
Accession:
GSE8140
ID:
200008140
6.

Expression data from MCF7/HER2-18 xenografts

(Submitter supplied) To investigate molecular mechanisms of resistance, we used two different in vivo xenograft models of estrogen receptor-positive (ER+) breast cancer, with or without HER2 over-expression (MCF7/HER2-18 and MCF7 wt, respectively). Mice with established tumors were assigned to the following treatment groups: continued estrogen supplementation (E2), estrogen deprivation (ED), ED plus tamoxifen (Tam), all with or without the EGFR tyrosine kinase inhibitor gefinitinib (G). more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
51 Samples
Download data: CEL, TXT
Series
Accession:
GSE8139
ID:
200008139
7.

Microarray analysis of rat mammary carcinogenesis

(Submitter supplied) 7,12-Dimethylbenz[a]anthracene (DMBA)-induced rat mammary carcinoma is a well-recognized model, however, the genetic alterations during its carcinogenesis have yet to be determined. We used laser capture microdissection to specifically isolate cells from terminal end buds (TEBs), the origin of carcinoma, at 2 weeks after sesame oil- treatment (control) or DMBA-treatment (DMBA-TEBs), ductal carcinoma in situ (DCIS) and invasive mammary carcinoma (MC). more...
Organism:
Rattus norvegicus
Type:
Expression profiling by array
Platform:
GPL7292
8 Samples
Download data: TXT, XLS
Series
Accession:
GSE13356
ID:
200013356
8.

LPS, Telmisartan and GW9662 treatment of microglial BV2 cells

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL16570
18 Samples
Download data: CEL, CHP
Series
Accession:
GSE108671
ID:
200108671
9.

LPS, Telmisartan and GW9662 co-treatment of microglial BV2 cells

(Submitter supplied) LPS, Telmisartan and GW9662 co-treatment of microglial BV2 cells.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL16570
6 Samples
Download data: CEL, CHP, TXT
Series
Accession:
GSE108670
ID:
200108670
10.

LPS and Telmisartan co-treatment of microglial BV2 cells

(Submitter supplied) LPS and Telmisartan co-treatment of microglial BV2 cells.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL16570
12 Samples
Download data: CEL, CHP, TXT
Series
Accession:
GSE108669
ID:
200108669
11.

Antisense miRNA-221/222 (si221/222) and control inhibitor (GFP) treated fulvestrant-resistant breast cancer cells

(Submitter supplied) Full title: Expression data from antisense miRNA-221/222 (si221/222) and control inhibitor (GFP) treated fulvestrant-resistant breast cancer cells The expression of miR-221/222 were found to be upregulated in fulvestrant resistant breast cancer cells MCF7-FR compared to its drug-sensitive counterpart MCF7. To investigate the role of miR-221/222 in acquired resistance to fulvestrant, we lowered the level of miR-221/222 in MCF7-FR cells using miRNA inhibitors (antagomirs), and compared gene expression profiles before and after treatment.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4054
Platform:
GPL570
9 Samples
Download data: CEL
Series
Accession:
GSE19777
ID:
200019777
12.
Full record GDS4054

microRNA-221/222 knockdown effect on fulvestrant-resistant MCF7 breast cancer cells

Analysis of fulvestrant-resistant MCF7 cells transfected with antisense miRNA inhibitors targeting miR-221 and miR-222. miR-221/222 knockdown inhibits cell proliferation in fulvestrant-resistant MCF7-F cells. Results provide insight into the role of miR-221/222 in acquired resistance to fulvestrant.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 3 genotype/variation sets
Platform:
GPL570
Series:
GSE19777
9 Samples
Download data: CEL
13.

Effects of oocyte-specific PIK3CA* transgene knock-in in ovaries

(Submitter supplied) To investigate the transcriptomic changes during the development and growth of ovarian granulosa cell tumors derived by oocyte-specific PIK3CA* transgene overexpression
Organism:
Mus musculus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL21626
9 Samples
Download data: XLSX
Series
Accession:
GSE233313
ID:
200233313
14.

Expression data from Sca-1 knockout mice

(Submitter supplied) The role of Sca-1 on mammary tumorigenesis was assessed. Microarrays were used to analyse global gene expression changes in Sca-1 KO mice versus wild-type mice and determine the differential responses to MP and DMBA-induced Mammary carcinogenesis
Organism:
Mus musculus
Type:
Expression profiling by array
Dataset:
GDS5500
Platform:
GPL8321
4 Samples
Download data: CEL
Series
Accession:
GSE31954
ID:
200031954
15.
Full record GDS5500

Stem cell antigen-1 deficient mammary tumor

Analysis of mammary tumors from mutants lacking stem cell antigen-1 (Sca-1), a glycerophosphatidylinositol-anchored protein. Tumorigenesis induced by medroxyprogesterone and 7,12dimethylbenz(a)anthracene treatment. Results provide insight into the role of Sca-1 in mammary gland tumorigenesis.
Organism:
Mus musculus
Type:
Expression profiling by array, count, 2 genotype/variation, 2 tissue sets
Platform:
GPL8321
Series:
GSE31954
4 Samples
Download data: CEL
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=4|blobid=MCID_66281a82862bea0a3f86b86f|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center